PB 110 of 2026
National Health (October 2026 Flow on price reductions for brands of combination items) (Exercise of Ministerial discretion) Determination 2026 (No.2)
I, Mike Pope, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following determination.
Dated 28 August 2026
MIKE POPE
Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division
Department of Health, Disability and Ageing
1 Name
(1) This instrument is the National Health (October 2026 Flow on price reductions for brands of combination items)(Exercise of Ministerial discretion) Determination 2026 (No.2).
(2) This instrument may also be cited as PB 110 of 2026.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
Sections 1 to 4 and Schedule 2 | Immediately after this instrument is registered | |
Sections 5 and 6, Schedule 1 and anything in this instrument not elsewhere covered in this table | 1 October 2026 | 1 October 2026 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 99ADHB(6) of the National Health Act 1953.
4 Schedule 2
Each instrument that is specified in Schedule 2 to this instrument is amended or repealed as set out in the applicable items in that Schedule, and any other item in that Schedule has effect according to its terms.
5 Definitions
Note: A number of expressions used in this instrument are defined in Part VII the Act.
In this instrument:
Act means the National Health Act 1953.
6 Brands of pharmaceutical item (combination items) with approved ex-manufacturer price not reduced
- I determine under paragraph 99ADHB(6) of the Act that, for the purposes of subsection 99ADHB(2), the approved ex-manufacturer price of each brand of pharmaceutical item specified in the table in Part 1 of Schedule 1 is not reduced on 1 October 2026.